Most common etiological variety of uveitis is:
**Question:** Most common etiological variety of uveitis is:
A. Autoimmune
B. Infectious
C. Vascular
D. Anterior
**Correct Answer:** A. Autoimmune
**Core Concept:** Uveitis refers to an inflammation of the layers surrounding the eyeball, including the iris, ciliary body, and choroid. Uveitis can be classified based on its cause and location.
**Why the Correct Answer is Right:** The correct answer is autoimmune uveitis because it is the most common etiological variety. Autoimmune uveitis occurs when the body's immune system mistakenly attacks the eye tissues, leading to inflammation. This type of uveitis is typically non-infectious, non-vascular, and affects the anterior segment of the eye.
**Why Each Wrong Option is Incorrect:**
A. **Infectious uveitis:** This is less common compared to autoimmune uveitis and is caused by various pathogens, such as viruses, bacteria, fungi, and parasites. Infectious uveitis is usually vascular, involving the entire uveal tract, and often presents with specific clinical features like vitritis and posterior synechiae.
B. **Vascular uveitis:** While uveitis can involve blood vessels, the correct answer is autoimmune uveitis as it is more common and not specifically related to vascular involvement. Vascular uveitis refers to inflammation involving the blood vessels in the uveal tract, which is a different type of uveitis.
C. **Anterior uveitis:** This misnomer is incorrect as it only describes the location of uveitis, not its cause. Anterior uveitis refers to inflammation affecting only the anterior segment of the eye, leaving the posterior segment unaffected. The correct answer is autoimmune uveitis, which can involve both anterior and posterior segments, depending on the extent of inflammation.
**Clinical Pearl:** It is essential for medical students and practicing physicians to differentiate between various types of uveitis as they have different causes, clinical features, and treatment approaches. This can help in accurate diagnosis and targeted therapy for patients with uveitis.